Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-29.5%
5Y CAGR-17.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-29.5%/yr
vs +0.7%/yr prior
5Y CAGR
-17.2%/yr
Recent deceleration
Acceleration
-30.2pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $25.08M | -37.1% |
| 2024 | $39.89M | -21.7% |
| 2023 | $50.91M | -28.9% |
| 2022 | $71.55M | -9.2% |
| 2021 | $78.80M | +22.4% |
| 2020 | $64.40M | -19.1% |
| 2019 | $79.58M | +14.3% |
| 2018 | $69.65M | +72.7% |
| 2017 | $40.33M | +63.1% |
| 2016 | $24.73M | - |